Jurickson Profar Receives Full-Season Suspension as MLB Enforces Second PED Violation Penalty

Major League Baseball has handed Atlanta Braves outfielder Jurickson Profar a 162-game suspension following a positive test for performance-enhancing drugs, marking his second violation within a year. The penalty, announced Tuesday, effectively sidelines Profar for an entire season under MLB’s Joint Drug Prevention and Treatment Program. Despite the ruling, the Major League Baseball Players Association plans to appeal the suspension, with sources indicating the process will be expedited.

MLB confirmed that Profar tested positive for exogenous testosterone and its metabolites, substances banned under league policy. Because this is his second offense, the punishment carries stricter consequences than a first violation. Unlike first-time offenders whose suspensions are typically paused during appeals, Profar’s penalty will proceed without a stay, meaning the suspension is scheduled to begin Friday regardless of the appeal outcome.

Second Violation Triggers Automatic Suspension as Braves Face Unexpected Roster Challenge Ahead

This latest incident follows a prior suspension during the 2025 season, when Profar missed 80 games after testing positive for human chorionic gonadotropin (hCG), a fertility drug often associated with steroid use and recovery cycles. That earlier violation already placed the veteran outfielder under heightened scrutiny, making the current penalty automatic and significantly more severe under league rules.

The Atlanta Braves expressed disappointment in an official statement, reaffirming their support for MLB’s drug prevention program and emphasizing that players are regularly educated on the league’s policies and consequences. The organization now faces a difficult roster situation, as Profar had been expected to play an important role in the team’s lineup during the upcoming season.

Profar’s Production, Financial Impact, and Appeal Define Braves’ Difficult Suspension Situation Ahead

After returning from his 2025 suspension, the 33-year-old appeared in 76 games and posted a respectable .245 batting average with a .353 on-base percentage, .434 slugging percentage, 14 home runs, and 43 RBIs. His offensive production provided stability for a Braves roster already dealing with pitching depth concerns following long-term injuries to key starters.

Financially, the suspension carries mixed implications for Atlanta. Profar was set to earn $15 million in salary, but because the Braves exceeded the luxury tax threshold, the team is projected to save approximately $18 million in total obligations, including tax penalties tied to payroll limits.

In a prior statement after his first suspension, Profar maintained that he never intentionally used banned substances but accepted responsibility for the violation. Now facing a full-season absence, his appeal represents the final opportunity to challenge the ruling, though precedent suggests overturning such penalties is rare.